Job Protection for Organ Donor Recovery

Full Title:
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.

Summary#

This bill adds organ donation surgery recovery to the list of illnesses that qualify as a "serious health condition" for family and medical leave rules. That means people who need time off to have an organ removed as a donor and to recover would clearly be covered by the Family and Medical Leave Act (FMLA) rules and similar federal civil service leave rules. For federal employees, the bill also says agencies should substitute any available paid leave for as much of that time as possible.

  • Main change: The text explicitly includes “recovery from surgery related to organ donation” in the legal definition of a serious health condition for both private-sector FMLA and federal civil service leave rules.
  • Federal employees: The bill directs that federal employees who use part of their 12-week FMLA period to serve as an organ donor should, where possible, substitute leave available under another federal leave rule.
  • Does not change FMLA length: It does not increase the total 12-week FMLA period or otherwise expand FMLA eligibility rules in this text.
  • Goal: Clarify that organ donors’ surgery recovery is a protected, qualifying reason for FMLA-type leave.

What it means for you#

  • Private-sector employees who qualify for FMLA (generally works for an employer with 50+ employees and meets service/time rules):

    • You would have a clear, explicit right to take FMLA leave to recover from organ donation surgery. That leave continues to be job-protected under existing FMLA rules.
    • Your employer must maintain any group health coverage during that leave the same way it does for other FMLA leave.
  • Federal civilian employees:

    • Recovery from organ donation surgery is explicitly a qualifying serious health condition.
    • Agencies must try to replace (substitute) as much of that FMLA time as possible with leave available under the cited federal leave provision. This could mean more of the time is paid if you have accrued leave available.
  • Employers (private and federal):

    • Private employers covered by FMLA must treat organ-donor recovery the same as other serious health conditions for leave and benefits purposes.
    • Federal agencies must apply the substitution rule for paid leave where possible and track that substitution.
  • People considering organ donation and their families:

    • The bill clarifies that job-protected time off for recovery is available, which could make it easier to plan surgery and recovery without losing a job.
  • Small employers not covered by FMLA:

    • If your employer is not covered by FMLA, this change does not create a new federal leave right for you.

Expenses#

No publicly available information.

Possible practical cost and administrative effects (based on the bill text):

  • Employers may face costs for keeping a job open, maintaining health benefits during leave, and covering absent workers.
  • Federal agencies may see increased use of paid leave if the substitution rule results in paid time off being used for donor recovery. That could affect payroll and leave accounting.
  • Employers and agencies may have small administrative costs to update leave policies and train HR staff about the clarified rule.
  • Any overall fiscal impact (federal budget effects or employer cost totals) is not provided in the bill materials.

Proponents' View#

  • The bill appears intended to remove uncertainty and ensure organ donors clearly qualify for protected medical leave.
  • This could be seen as supporting organ donation by making job protection and benefit continuation explicit for recovery from donation surgery.
  • Clarifying the law may reduce disputes between employees and employers about whether donor surgery recovery counts as a serious health condition.

Opponents' View#

  • One concern is that the bill does not provide a fiscal estimate, so the total cost to employers or the federal government is unclear.
  • The bill does not clearly say whether time spent on pre-surgery evaluations, testing, or travel for donation is covered; it only mentions recovery from surgery.
  • The federal substitution rule could raise questions about employee choice: it is unclear whether employees must use accrued paid leave first, or whether substitution is optional in every case.
  • Employers may face administrative burdens to update practices and document leave, even if the legal protection is only a clarification.